Search SIGA
SIGA TECHNOLOGIES INC
Nasdaq · CIK 1010086
Last close3.38
Daily change+0.03 (0.90%)
10 Years gain+102.67%
Dividends TTM0.6 (+0.00%)
Dividend yield17.91%
Fundamental Analysis
SIGA · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
52.0Momentum
100.0Acceleration
100.0Confidence
86.0Annual Revenue10
Quarterly Revenue39
Annual CFO17
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth11.8 / 25
Quality5.3 / 25
Capital Efficiency20.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 17.0709 percentage points.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 8.9943 percentage points.
Key Metrics
Revenue Growth TTM103.74%OK
Revenue CAGR 3Y-5.13%OK
Gross Margin64.07%OK
Operating Margin33.62%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC57.5%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y0.64%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $94.57M | $64.87M | $23.70M | $43.47M | n/a | 68.59% | 25.06% | n/a | 34.84% | 71.87M |
| 2025 FY Dec 31, 2024 | $138.72M | $107.43M | $69.98M | $48.76M | n/a | 77.44% | 50.45% | n/a | 101.71% | 71.91M |
| 2025 FY Dec 31, 2023 | $139.92M | $122.09M | $83.62M | $94.80M | n/a | 87.26% | 59.76% | n/a | 109.83% | 71.68M |
| 2024 FY Dec 31, 2022 | $110.78M | $100.34M | $42.70M | $41.61M | n/a | 90.58% | 38.55% | n/a | 46.03% | 73.55M |
| 2023 FY Dec 31, 2021 | $133.67M | $117.07M | $89.09M | $11.49M | n/a | 87.58% | 66.65% | n/a | 166.78% | 76.4M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $130.98M | sum latest 4 fiscal quarters Revenue | OK | 0001437749-26-026314, 0001437749-25-033636 |
| Revenue Growth TTM | 103.74% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001437749-26-026314, 0001437749-25-033636 |
| Revenue CAGR 3Y | -5.13% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001437749-26-007557 |
| Revenue CAGR 5Y | -5.42% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001437749-26-007557 |
| Gross Profit CAGR 3Y | -13.53% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001437749-26-007557 |
| Operating Income Growth | 313.85% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001437749-26-026314, 0001437749-25-033636 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 64.07% | Gross Profit / Revenue | OK | 0001437749-26-026314, 0001437749-25-033636 |
| Operating Margin | 33.62% | Operating Income / Revenue | OK | 0001437749-26-026314, 0001437749-25-033636 |
| ROIC | 57.5% | NOPAT / Average Invested Capital | OK | 0001437749-26-026314, 0001437749-25-033636 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001437749-26-026314 |
| Current Ratio | 21.72x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $1.82 | Revenue / Diluted Shares | OK | 0001437749-26-026314, 0001437749-25-033636 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |